Top 3 Health Care Stocks You'll Regret Missing This Quarter - ProKidney (NASDAQ:PROK), RadNet (NASDAQ:RDNT)

The most oversold stocks in the health care sector presents an opportunity to buy into undervalued companies.

The RSI is a momentum indicator, which compares a stock’s strength on days when prices go up to its strength on days when prices go down. When compared to a stock’s price action, it can give traders a better sense of how a stock may perform in the short term. An asset is typically considered oversold when the RSI is below 30, according to Benzinga Pro.

Here’s the latest list of major oversold players in this sector, having an RSI near or below 30.

Radnet Inc RDNT

On March 5, Raymond James analyst John Ransom upgraded RadNet from Outperform to Strong Buy and lowered the price target from $85 to $65.. The company’s stock fell around 24% over the past month and has a 52-week low of $42.45.
RSI Value: 24.8
RDNT Price Action: Shares of Radnet fell 4.1% to close at $47.24 on Wednesday.
Benzinga Pro’s real-time newsfeed alerted to latest RDNT news.

Tactile Systems Technology Inc TCMD

On Feb. 18, Tactile Systems Tech posted better-than-expected quarterly earnings. “Our fourth quarter results capped off a dynamic year for Tactile, during which we launched our next-generation lymphedema platform, generated clinical evidence supporting the value of our therapies, deployed new workflow-related tools to enhance speed and efficiency in order operations, and served over 79,000 patients with our lymphedema and airway clearance solutions,” said Sheri Dodd, President and Chief Executive Officer of Tactile Medical. The company’s stock fell around 22% over the past month and has a 52-week low of $11.12.
RSI Value: 22.5
TCMD Price Action: Shares of Tactile Systems Technology fell 4.7% to close at $13.26 on Wednesday.
Benzinga Pro’s charting tool helped identify the trend in TCMD stock.

ProKidney Corp PROK

On Nov. 12, 2024, ProKidney posted a narrower-than-expected quarterly loss. The company’s stock fell around 38% over the past month and has a 52-week low of $0.94.
RSI Value: 25.9
PROK Price Action: Shares of ProKidney fell 5.3% to close at $0.99 on Wednesday.
Benzinga Pro’s signals feature notified of a potential breakout in PROK shares.